ストックスクリーナーアプリを入手
14.61
1.55%
-0.23
アフターアワーズ：
14.61
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics (NEO) Stock Looks Above Fair Value After A 134% Run - Yahoo Finance Singapore
Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch? - Yahoo Finance
NGMS stock holds its ground after Neogenomics revenue trends improve - ad-hoc-news.de
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? - The Globe and Mail
ETFs Investing in NeoGenomics, Inc. Stocks - TradingView
Bank of America Securities Reaffirms Their Hold Rating on NeoGenomics (NEO) - The Globe and Mail
Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift? - simplywall.st
NeoGenomics, Inc. Stock 12‑Month Price Target Raised to $15.67, Implies 11% Upside - TradingView
NeoGenomics Q1 2026 Earnings: Narrow Profit Beats Estimates Amid Market SkepticismRevenue Guidance Range - dars.gov.et
NeoGenomics Inc (NEO) Shares Fall 4.2% -- What GF Score of 72 Te - GuruFocus
NeoGenomics launches $275M convertible notes offering due 2032 - MSN
Press Release: NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 - 富途牛牛
NeoGenomics (NEO) stock trades up, here is why - MSN
NeoGenomics (NEO) Stock Trades Up, Here Is Why - Yahoo Finance
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer - BioSpace
NeoGenomics launches FDA-approved prostate cancer diagnostic test - Investing.com
NeoGenomics launches FDA-approved prostate cancer diagnostic test By Investing.com - Investing.com India
(NEO) Volatility Zones as Tactical Triggers - Stock Traders Daily
NeoGenomics Inc focuses on diagnostics growth as investors watch long-term margins - Ad-hoc-news.de
NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 - BioSpace
NeoGenomics on Track for Longest Winning Streak Since February 2019 -- Data Talk - Moomoo
Neogenomics stock hits 52-week high at 15.56 USD By Investing.com - Investing.com South Africa
Neogenomics stock hits 52-week high at 15.56 USD - Investing.com
NEONeogenomics Inc Latest SEC Filings - Finviz
Is NeoGenomics (NEO) Quietly Reframing Its Oncology Data Strategy With Starrett’s Board Appointment? - simplywall.st
Price-Driven Insight from (NEO) for Rule-Based Strategy - Stock Traders Daily
NeoGenomics, Inc. Actuals & Estimates (NASDAQ:NEO) - TradingView
Enterprise value to EBITDA forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
Price to sales forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
Enterprise value to EBITDA forward of NeoGenomics, Inc. – MUN:NG9 - TradingView
NeoGenomics, Inc. Actuals & Estimates (BX:NG9) - TradingView
Price to book forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
NeoGenomics, Inc. Actuals & Estimates (SWB:NG9) - TradingView
Price to earnings forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
Enterprise value to EBIT forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
Price to earnings forward of NeoGenomics, Inc. – LSX:120159 - TradingView
NeoGenomics, Inc. Hits New 52-Week High at $13.87 - MarketsMojo
Carolyn Starrett joins NeoGenomics board of directors team - Gulfshore Business
Enterprise value to revenue forward of NeoGenomics, Inc. – NASDAQ:NEO - TradingView
Enterprise value to EBITDA forward of NeoGenomics, Inc. – LSX:120159 - TradingView
A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance
NeoGenomics stock rallies to new highs with overbought signals raising volatility risk - Traders Union
NEO Forecast — Price Target — Prediction for 2027 - TradingView
Neogenomics stock hits 52-week high at 13.74 USD - Investing.com UK
Neogenomics stock hits 52-week high at 13.74 USD By Investing.com - Investing.com South Africa
NeoGenomics (NASDAQ: NEO) director receives new RSU and stock option grants - Stock Titan
NeoGenomics (NEO) director Carolyn Starrett files initial Form 3 - Stock Titan
NeoGenomics, Inc. Announces Appointment of Carolyn Starrett to Board of Directors - marketscreener.com
NeoGenomics Appoints Carolyn Starrett to its Board of Directors - 01net
NeoGenomics Taps AI Veteran for Board, Signaling Data-Driven Future - BriefGlance
NeoGenomics appoints Carolyn Starrett to board of directors By Investing.com - Investing.com Australia
NeoGenomics Appoints Carolyn Starrett to Board of Directors - citybiz
NeoGenomics Adds Data-Focused Independent Director to Board - TipRanks
NeoGenomics appoints Carolyn Starrett to board of directors - Investing.com
0.61%
1.88%
大文字化:
|
ボリューム (24 時間):